BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38242007)

  • 1. Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix.
    Pavelková L; Táborská E; Syding LA; Plačková K; Simonova E; Hladíková K; Hensler M; Laco J; Koucký V; Zábrodský M; Bouček J; Grega M; Rozkošová K; Vošmiková H; Halaška MJ; Rob L; Práznovec I; Hodek M; Vošmik M; Čelakovský P; Chrobok V; Ryška A; Palová-Jelínková L; Špíšek R; Fialová A
    Transl Oncol; 2024 Mar; 41():101884. PubMed ID: 38242007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
    Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
    Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
    J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
    Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
    J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
    Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
    Front Immunol; 2021; 12():798424. PubMed ID: 35145511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors.
    Stern PL; Dalianis T
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cells of epithelial, connective tissue and immune differentiation in HPV-positive-, HPV-negative oropharyngeal carcinoma and normal oropharyngeal tissue by immunofluorescence multiplex image cytometry: a preliminary report.
    Giotakis AI; Runge A; Dudas J; Glueckert R; Gottfried T; Schartinger VH; Klarer J; Randhawa A; Caimmi E; Riechelmann H
    BMC Cancer; 2023 Nov; 23(1):1154. PubMed ID: 38012597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
    Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
    Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The tumor microenvironment-relay station for prognosis and therapy response].
    Krupar R
    Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):141-147. PubMed ID: 36414699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma.
    Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ
    Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
    BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival.
    Santegoets SJ; van Ham VJ; Ehsan I; Charoentong P; Duurland CL; van Unen V; Höllt T; van der Velden LA; van Egmond SL; Kortekaas KE; de Vos van Steenwijk PJ; van Poelgeest MIE; Welters MJP; van der Burg SH
    Clin Cancer Res; 2019 Jan; 25(1):240-252. PubMed ID: 30224343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
    Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM
    Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
    Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
    Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD73 expression in myeloid-derived suppressor cells is correlated with clinical stages in head and neck squamous cell carcinomas.
    Zheng W; Zhu Y; Chen X; Zhao J
    Ann Transl Med; 2021 Jul; 9(14):1148. PubMed ID: 34430589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
    J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer.
    Zech HB; Berger J; Mansour WY; Nordquist L; von Bargen CM; Bußmann L; Oetting A; Christiansen S; Möckelmann N; Böttcher A; Busch CJ; Petersen C; Betz C; Rothkamm K; Kriegs M; Köcher S; Rieckmann T
    Radiother Oncol; 2022 Mar; 168():138-146. PubMed ID: 35093407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma.
    Gurin D; Slavik M; Hermanova M; Selingerova I; Kazda T; Hendrych M; Shatokhina T; Vesela M
    J Oral Pathol Med; 2020 Oct; 49(9):886-896. PubMed ID: 32516834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
    van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
    Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.